scholarly journals Value BREAST Cancer Care: a pilot project to build a population and value based system of care

2017 ◽  
Vol 27 (suppl_3) ◽  
Author(s):  
R Pastorino ◽  
P Parente ◽  
A Barbara ◽  
M Di Pumpo ◽  
A Tognetto ◽  
...  
2016 ◽  
Vol 34 (7_suppl) ◽  
pp. 208-208
Author(s):  
Rachel Adilman ◽  
Christine E. Simmons ◽  
Maryam Eslami ◽  
Caroline Illmann ◽  
Rebecca Warburton ◽  
...  

208 Background: Breast cancer management has become exceedingly collaborative across specialties. Preoperative multidisciplinary input in particular is increasingly needed as indications for neoadjuvant therapy (NAT) continue to expand. In British Columbia, as in many other regions, breast cancer surgery is typically performed by community surgeons working in settings away from medical and radiation oncologists, making preoperative multidisciplinary input challenging. Methods: This prospective pilot study was designed to enhance and streamline preoperative breast cancer care at the BC Cancer Agency Vancouver Centre (BCCA) and Mount Saint Joseph’s Hospital (MSJ). Patients with a new diagnosis of breast cancer at the MSJ Breast Clinic are included in this pilot triage project if tumors meet one or more of the following criteria: triple negative, HER2+, clinically palpable ≥ 2cm, or present with positive/palpable nodes. Before the patient has consulted with a surgeon, the pathology, imaging, and GP’s assessment is faxed by a MSJ nurse navigator to BCCA for preoperative triage by a medical oncologist. A BCCA navigator facilitates this confidential electronic triage process, and communicates the medical oncologist’s recommendation [a) urgent referral for NAT, or b) upfront surgery] back to MSJ for appropriate booking and management. Results: Since inception in November 2014, 42 patients have undergone electronic preoperative triage through this pilot project. Of those, 47.6% were recommended to have, and did have, a preoperative medical oncology consult to discuss NAT. 90% of patients who had a NAT consult ultimately received NAT compared to a 66% uptake of NAT through the traditional referral process (P = 0.029). Median wait time from ‘biopsy result’ to ‘start of chemotherapy’ was significantly reduced by 9 days through this novel triage process (P = 0.047). Conclusions: This preoperative multidisciplinary triage project has significantly reduced treatment wait times and improved patient selection for and uptake of NAT for breast cancer. Breast cancer care benefits from increased preoperative navigation to help streamline and expedite care for high-risk patients.


2021 ◽  
Author(s):  
Isabel Alvarado‐Cabrero ◽  
Franco Doimi ◽  
Virginia Ortega ◽  
Jurema Telles Oliveira Lima ◽  
Rubén Torres ◽  
...  

2021 ◽  
pp. 000313482096628
Author(s):  
Erica Choe ◽  
Hayoung Park ◽  
Ma’at Hembrick ◽  
Christine Dauphine ◽  
Junko Ozao-Choy

Background While prior studies have shown the apparent health disparities in breast cancer diagnosis and treatment, there is a gap in knowledge with respect to access to breast cancer care among minority women. Methods We performed a retrospective analysis of patients with newly diagnosed breast cancer from 2014 to 2016 to evaluate how patients presented and accessed cancer care services in our urban safety net hospital. Patient demographics, cancer stage, history of breast cancer screening, and process of referral to cancer care were collected and analyzed. Results Of the 202 patients identified, 61 (30%) patients were younger than the age of 50 and 75 (63%) were of racial minority background. Only 39% of patients with a new breast cancer were diagnosed on screening mammogram. Women younger than the age of 50 ( P < .001) and minority women ( P < .001) were significantly less likely to have had any prior screening mammograms. Furthermore, in patients who met the screening guideline age, more than half did not have prior screening mammograms. Discussion Future research should explore how to improve breast cancer screening rates within our county patient population and the potential need for revision of screening guidelines for minority patients.


2019 ◽  
Vol 229 (4) ◽  
pp. S260-S261
Author(s):  
Sarah P. Shubeck ◽  
Margaret E. Smith ◽  
Ton Wang ◽  
Tasha Hughes ◽  
Lesly A. Dossett

1998 ◽  
Vol 5 (4) ◽  
pp. 338-345
Author(s):  
John Horton

Background Breast cancer is a significant cause of mortality and morbidity worldwide, although death rates in the United States and some other countries are beginning to fall. Methods Several sources of information in 1998, including publications and presentations at the 1998 meeting of the American Society of Clinical Oncology, are pertinent to contemporary breast cancer care. Results It is now possible to prescribe hormonal therapy that will reduce the incidence of breast cancer. Methods are available to reduce the morbidity from axillary node dissection, and improvements in adjuvant therapy and management of metastatic breast cancer are now at hand. Conclusions The information presented provides a broad-based platform for new standards of care for breast cancer that will serve as a sound base for further progress in this important disease.


Sign in / Sign up

Export Citation Format

Share Document